Tazowok 500mg/62.5mg Injection
Marketer
Wockhardt Ltd
Salt Composition
Cefepime (500mg) + Tazobactum (62.5mg)
Overview Tazowok 500mg/62.5mg Injection
Combiflox 500 mg/62.5 mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under a healthcare provider's guidance. Consistent adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Typical mild reactions include nausea, vomiting, diarrhea, and skin rashes; injection site inflammation and discomfort may also occur, typically resolving spontaneously. Severe or persistent side effects warrant immediate medical attention. Seek immediate help for allergic responses (e.g., hives, itching, swelling, respiratory distress). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Uses of Tazowok 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Tazowok 500mg/62.5mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazowok 500mg/62.5mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Tazowok 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Tazowok 500mg/62.5mg Injection works:
Tazowok, a 500mg/62.5mg injectable formulation, combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes (beta-lactamases) that would otherwise neutralize cefepime. This synergistic effect broadens cefepime's antibacterial spectrum and diminishes bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Tazowok 500 mg/62.5 mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazowok 500 mg/62.5 mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazowok, 500 mg/62.5 mg, presents minimal risk during lactation. Research in humans indicates negligible transfer of the drug into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
Following administration of Tazowok 500 mg/62.5 mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Individuals with impaired kidney function should use Tazowok 500 mg/62.5 mg Injection with careful monitoring. Dosage modification of Tazowok 500 mg/62.5 mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazowok 500 mg/62.5 mg Injection in patients with liver impairment appears to pose minimal risk. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Tazowok 500mg/62.5mg Injection :
Omit a Tazowok 500 mg/62.5 mg Injection dose? Seek your physician's advice.
Facts to Know About Tazowok 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently